These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24565386)

  • 41. The influence of the age of the rat on the neuromuscular response to mivacurium in vitro.
    Yang HS; Goudsouzian NG; Cheng M; Martyn JA
    Paediatr Anaesth; 1996; 6(5):367-72. PubMed ID: 8880816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Congenital pseudocholinesterase deficiency].
    Gelo R; Jurek-Gelo A; Wardaszko R; Kański A
    Anestezjol Intens Ter; 2011; 43(1):33-5. PubMed ID: 21786528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of the anesthetic effects of mivacurium and cisatracurium besylate in laser laryngeal microsurgery].
    Wu LL; Luo H; Lei GY; Lu JF; Chen YM; Hu CH; Chen HY; Wei Z; Xi CH; Wang GY
    Zhonghua Yi Xue Za Zhi; 2022 Jun; 102(21):1574-1578. PubMed ID: 35644957
    [No Abstract]   [Full Text] [Related]  

  • 44. Unexpected prolonged neuromuscular block after mivacurium: a case report.
    Hemadri M; Purva M; Traykova V
    Med Princ Pract; 2002; 11(1):50-2. PubMed ID: 12116697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis.
    Naik B; Hirshhorn S; Dharnidharka VR
    J Clin Anesth; 2002 Aug; 14(5):381-4. PubMed ID: 12208445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase.
    Baraka A
    Anesthesiology; 1995 Dec; 83(6):1371-2. PubMed ID: 8533937
    [No Abstract]   [Full Text] [Related]  

  • 47. Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade.
    Naguib M; el-Gammal M; Daoud W; Ammar A; Moukhtar H; Turkistani A
    Anesthesiology; 1995 May; 82(5):1288-92. PubMed ID: 7741305
    [No Abstract]   [Full Text] [Related]  

  • 48. Sensitivity to mivacurium in a patient with mitochondrial myopathy.
    Naguib M; el Dawlatly AA; Ashour M; al-Bunyan M
    Anesthesiology; 1996 Jun; 84(6):1506-9. PubMed ID: 8669694
    [No Abstract]   [Full Text] [Related]  

  • 49. [Development of a new closed-loop system for controlling mivacurium-induced neuromuscular blockade].
    Geldner G; Schwarz U; Ruoff M; Romeiser J; Lendl M; Schütz W; Georgieff M
    Anaesthesist; 1999 Mar; 48(3):157-62. PubMed ID: 10234396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonism of residual mivacurium blockade: setting the record straight.
    Savarese JJ; Lien CA; Belmont MR
    Anesthesiology; 1996 Jun; 84(6):1525-8. PubMed ID: 8669705
    [No Abstract]   [Full Text] [Related]  

  • 51. Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange.
    Collard CD; Baker BW; Johnson D; Bressler R; Harati Y
    J Clin Anesth; 1996 Feb; 8(1):44-8. PubMed ID: 8695079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pre-emptive glycopyrrolate 0.2 mg and bradycardia during gynaecological laparoscopy with mivacurium.
    Ambrose C; Buggy D; Farragher R; Troy A; McNulty C; Carey M
    Eur J Anaesthesiol; 1998 Nov; 15(6):710-3. PubMed ID: 9884857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between mivacurium and prilocaine.
    Wildsmith JA
    Br J Anaesth; 1997 Aug; 79(2):262. PubMed ID: 9349138
    [No Abstract]   [Full Text] [Related]  

  • 54. The train-of-four count and recovery from mivacurium.
    Kopman AF
    Anesth Analg; 1999 Aug; 89(2):536. PubMed ID: 10439789
    [No Abstract]   [Full Text] [Related]  

  • 55. Nonlinear model-based predictive control of non-depolarizing muscle relaxants using neural networks.
    Lendl M; Schwarz UH; Romeiser HJ; Unbehauen R; Georgieff M; Geldner GF
    J Clin Monit Comput; 1999 Jul; 15(5):271-8. PubMed ID: 12568132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prolonged neuromuscular block induced by mivacurium in a patient with acquired immunodeficiency syndrome].
    López MA; Vilaplana J; Obón Ferrer M; Fernández MA; Balanzá Roure R; Soler Simón S
    Rev Esp Anestesiol Reanim; 1998; 45(6):255. PubMed ID: 9719725
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on mivacurium.
    From RP; Pearson KS; Choi WW; Sokoll MD
    Br J Anaesth; 1991 Mar; 66(3):416. PubMed ID: 1826605
    [No Abstract]   [Full Text] [Related]  

  • 58. Mivacurium administration in children with Duchenne muscular dystrophy.
    Tobias JD; Uslu M
    Anesth Analg; 2000 Feb; 90(2):498-9. PubMed ID: 10648347
    [No Abstract]   [Full Text] [Related]  

  • 59. Prolonged paralysis following mivacurium administration.
    Chung DY; Hardman J
    Anaesth Intensive Care; 2002 Jun; 30(3):360-3. PubMed ID: 12075646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mivacurium in multicore disease.
    Münster T; Schmitt HJ
    Anaesth Intensive Care; 2006 Jun; 34(3):401. PubMed ID: 16802504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.